Electrochemical/I– Dual-Catalyzed Access to Sulfonated Pyrazoles under External Oxidant-Free Conditions
SynOpen · 01.06.2023 · 07 (02) · 272-276
DOI: 10.1055/a-2089-0485 ↗Kurz gefasst
Fachartikel in der Zeitschrift SynOpen, erschienen am 01.06.2023. Verfasst von Jing Ma und 9 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Qufu Normal University.
Abstract (Originalsprache)
An electrochemical/I– dual-catalyzed access to sulfonated pyrazoles from pyrazolones and sodium sulfites under external oxidant-free conditions has been developed. This established electrochemical reaction works smoothly under external oxidant-free conditions and has the advantages of good functional group tolerance, easy to gram-scale synthesis, delivering up to 95% yield for 35 examples.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Qufu Normal University
Zitieren
APA
Ma, J., Yang, J., Wen, J., Yan, K., Luo, B., Huang, K., Wu, Z., Zhou, Y., Zhu, S., & Zhao, X. (2023). Electrochemical/I– Dual-Catalyzed Access to Sulfonated Pyrazoles under External Oxidant-Free Conditions. SynOpen, 07(02), 272-276. https://doi.org/10.1055/a-2089-0485
Vancouver
Ma J, Yang J, Wen J, Yan K, Luo B, Huang K, et al. Electrochemical/I– Dual-Catalyzed Access to Sulfonated Pyrazoles under External Oxidant-Free Conditions. SynOpen. 2023;07(02):272-276. doi:10.1055/a-2089-0485
BibTeX
@article{Ma2023,
author = {Ma, Jing and Yang, Jianjing and Wen, Jiangwei and Yan, Kelu and Luo, Boju and Huang, Kexin and Wu, Ziling and Zhou, Yumeng and Zhu, Shuyun and Zhao, Xian-En},
title = {Electrochemical/I– Dual-Catalyzed Access to Sulfonated Pyrazoles under External Oxidant-Free Conditions},
journal = {SynOpen},
year = {2023},
volume = {07},
number = {02},
pages = {272--276},
doi = {10.1055/a-2089-0485}
}
EUVIMED